Science and Healthcare for Welfare (SHoW) cares about Oral infections (SHOW)... but not only!
“Ayez le culte de l'esprit critique.”
(Worship critical thinking)
Louis Pasteur, 1887
OUR QUEST
-
We work on accelerating the advent of a post-personalized medicine age for infection management.
-
We aim at developing tomorrow’s diagnostic tools and advanced therapy medicinal products.
-
We believe the societal empowerment will result from technological breakthroughs, proposing solutions that will be valid for all individuals
SHoW, we care!
about all infectious diseases
(not only periodontitis!)
![Navigation dans Woods](https://static.wixstatic.com/media/8fe4c1474ae143b91a8a29a578298d45.jpg/v1/fill/w_490,h_317,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/8fe4c1474ae143b91a8a29a578298d45.jpg)
![Brouillon.jpg](https://static.wixstatic.com/media/f2a83c_0aef8d8ecace435d89af363486cd1d65~mv2.jpg/v1/crop/x_236,y_69,w_490,h_872,q_85,enc_auto/f2a83c_0aef8d8ecace435d89af363486cd1d65~mv2.jpg)
THE CURRENT SITUATION
The patients are sick because:
-
the prophylaxis can be:
-
a social turn-off (masks, condoms)
-
an economical burden (lockdown, PPE)
-
a health compromise (preventive drugs)
-
-
the diagnosis can be:
-
late due to late symptoms onset (HIV)
-
misleading due to erroneous symptom detection
-
false due to diagnosis tool specificities
-
expensive, in particular if repeated
-
unreachable, if specialized practitionners are to be consulted
-
-
the therapy can be:
-
late, due to late diagnosis
-
not targeted to the diseased site or to the infectious agent
-
not proportionate in magnitude and time
-
WE BRING A NEW LIGHT
We propose new biotechnology-based solutions:
-
microbiota-based active prophylaxis:
-
no social impact
-
low economical impact
-
no side-effects
-
-
next-generation diagnosis:
-
early
-
assumption-free (unbiased)
-
accurate
-
cheap
-
accessible (self-test)
-
-
self-regulated precision therapy:
-
early, before symptom onset
-
self-controlled, pathogen-triggered and thus:
-
local
-
proportionate
-
-
![Ampoule.jpg](https://static.wixstatic.com/media/f2a83c_9c0532269dfd45d7ab45d8ec3fb5bb8d~mv2.jpg/v1/crop/x_162,y_103,w_490,h_808,q_85,enc_auto/f2a83c_9c0532269dfd45d7ab45d8ec3fb5bb8d~mv2.jpg)
![](https://static.wixstatic.com/media/f2a83c_5707ef1cb2ff48078f0a58f8ed5fdb4c~mv2.jpg/v1/crop/x_85,y_0,w_490,h_239,q_80,enc_auto/f2a83c_5707ef1cb2ff48078f0a58f8ed5fdb4c~mv2.jpg)
OUR TEAM
-
Julien Santi-Rocca, PhD
-
CEO
-
Co-Founder
-
Biotech Innovation and Clinical Research
-
-
David Felipe Martín-García, PhD
-
CMO
-
Co-Founder
-
Social Sciences and Consumer Behaviour
-
-
Hakan Ümit, PhD
-
CFO
-
Business Developper
-
EU Funding and Legal Aspects
-